gemcitabine has been researched along with Micrometastases, Neoplasm in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Guo, YH; Liao, ZJ; Nan, KJ; Xu, R; Yao, JT; Zhao, Z | 1 |
| Asao, T; Fujii, T; Kato, T; Kuwano, H; Osone, K; Suto, T; Takada, T; Takahashi, R; Tatsuki, H; Tsutsumi, S; Yajima, R; Yokobori, T | 1 |
2 other study(ies) available for gemcitabine and Micrometastases, Neoplasm
| Article | Year |
|---|---|
Gemcitabine inhibits the micrometastasis of non-small cell lung cancer by targeting the EpCAM-positive circulating tumor cells via the HGF/cMET pathway.
Topics: Aged; Antigens, Neoplasm; Antimetabolites, Antineoplastic; Blotting, Western; Carcinoma, Non-Small-Cell Lung; Cell Adhesion Molecules; Cell Line, Tumor; Deoxycytidine; Epithelial Cell Adhesion Molecule; Epithelial-Mesenchymal Transition; Female; Flow Cytometry; Gemcitabine; Hepatocyte Growth Factor; Humans; Immunohistochemistry; Kaplan-Meier Estimate; Lung Neoplasms; Male; Middle Aged; Neoplasm Micrometastasis; Neoplastic Cells, Circulating; Pilot Projects; Real-Time Polymerase Chain Reaction; Reverse Transcriptase Polymerase Chain Reaction; Signal Transduction | 2014 |
Establishment of a novel method to evaluate peritoneal microdissemination and therapeutic effect using luciferase assay.
Topics: Animals; Antimetabolites, Antineoplastic; Biomarkers, Tumor; Cell Line, Tumor; Deoxycytidine; Female; Gemcitabine; Luciferases; Mice, Inbred BALB C; Neoplasm Micrometastasis; Neoplasm Transplantation; Optical Imaging; Peritoneal Neoplasms; Whole Body Imaging; Xenograft Model Antitumor Assays | 2016 |